Ikarian Capital LLC 13D/13G Filings for X4 Pharmaceuticals, Inc. (XFOR)

Ikarian Capital LLC 13D and 13G filings for X4 Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
11:26 am
Sale		 2022-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 Ikarian Capital LLC 349,133
0.300%		 -1,915,358decrease
(-84.58%)		 Filing
2022-02-14
4:43 pm
Sale		 2021-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 Ikarian Capital LLC 2,264,491
8.100%		 -360,497decrease
(-13.73%)		 Filing
2021-04-08
09:02 am
Purchase		 2021-03-23 13G X4 Pharmaceuticals, Inc.
XFOR		 Ikarian Capital LLC 2,624,988
11.100%		 1,798,564increase
(+217.63%)		 Filing
2020-12-30
5:26 pm
Purchase		 2020-12-29 13G X4 Pharmaceuticals, Inc.
XFOR		 Ikarian Capital LLC 826,424
5.100%		 826,424increase
(New Position)		 Filing